Early and late toxicity of radioiodine therapy: detection and management.
OBJECTIVE
To review the early and late toxicity associated with radioiodine (131I) therapy, highlighting the need for early detection and, where possible, preventive measures.


METHODS
We performed a literature search on MEDLINE using the terms radioiodine, 131I toxicity, complications, Graves disease, and thyroid cancer and chose the most relevant studies for this review. Where appropriate, we refer to our own published series of patients as well.


RESULTS
Uptake of 131I into the salivary glands, lacrimal glands, fetal thyroid, and adult thyroid accounts for the early toxic effects of radioiodine therapy. Delayed radiation effects to the gonads, bone marrow, and cell nuclei give rise to late complications. Toxicity may also arise from uptake into metastatic tumors located at vulnerable sites, including the spinal cord, brain, and lungs.


CONCLUSIONS
Although radioiodine therapy for benign and malignant thyroid disorders is usually well tolerated, clinicians involved in the management of thyroid disorders need to be aware of the potential toxicity of radioiodine and take all measures to reduce these effects to a minimum.
Hyer
Steve L
SL
Department of Endocrinology, St. Helier University Hospital, Surrey, UK. steve.hyer@esth.nhs.uk
Newbold
Kate
K
Harmer
Clive L
CL
D006111:Graves Disease / Q000209:etiology; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects*; D013959:Thyroid Diseases / Q000209:etiology; D013961:Thyroid Gland / Q000528:radiation effects*; D013964:Thyroid Neoplasms / Q000209:etiology
D007457:Iodine Radioisotopes